CATE Trial Launched to Show ctDNA-Guided Breast Cancer Treatment
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced its collaboration with a leading breast cancer team from Yale Cancer...
Category : Healthcare and Pharmaceutical
QIAGEN Earns CE-IVDR Certification for Full QIAstat-Dx Portfolio
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it has achieved CE-IVDR certification for its full portfolio of QIAstat-Dx syndromic testing systems and...
Recuro Health Promotes Michael Brombach as EVP and COO
Recuro Health today announced the promotion of Michael Brombach to Executive Vice President and Chief Operating Officer (COO), recognizing his role in driving the company’s significant growth and...
Contrast Ultrasound Shows 100% Accuracy for Kidney Tumor Detection
Contrast enhanced ultrasound (CEUS) is superior to contrast magnetic resonance (MR) and computed tomography (CT), and offers 100% sensitivity and specificity, for finding residual or...
VUMI® Canada Celebrates 5 Years Transforming Healthcare Access
VUMI® Canada proudly marked its 5th anniversary yesterday with an exclusive luxury event in Toronto, joined by top brokers and partners. The celebration highlighted the...
Incyte to Present New Data at European Dermatology Congress 2025
24-week data from the Phase 3 STOP-HS clinical trial program of povorcitinib in patients with hidradenitis suppurativa (HS) selected as a late-breaking oral presentation Today...
CAPVAXIVE® Shows Positive Immune Response in At-Risk Youth
Results from the Phase 3 STRIDE-13 trial presented at the 6th ESCMID Conference on Vaccines Merck to share STRIDE-13 results with global regulatory authorities Merck (NYSE:...
NCCN Summit Explores AI’s Role in Safe, Equitable Cancer Care
During an Oncology Policy Summit hosted by the National Comprehensive Cancer Network, experts weighed in on whether medical technology is ready for its next big...
Seegene, Springer Nature Open 2025–26 MDx Grant Applications
The program focuses on antibiotic resistance in urinary tract infections (UTI-DR), with applications open until November 20; final awardees to be announced in August 2026Selected researchers will...
IgniteData Expands Archer Platform at Top Research Centers
IgniteData, the leading clinical research data technology company transforming how healthcare data flows into clinical trials, today announced the significant global expansion of its flagship...
Noxilizer Raises $30M to Expand NO₂ Sterilization Capacity
Investment accelerates global adoption of Noxilizer’s terminal sterilization alternative that is validated, safe, scalable and sustainable for biopharmaceutical and medical device manufacturers Noxilizer, Inc. (“Noxilizer”), the leader...
Karyopharm Completes Enrollment in Phase 3 SENTRY Trial
Top-Line Results Anticipated in March 2026 Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that it has completed enrollment in...
Tenovi Joins Leadership Council to Advance Connected Care Access
Tenovi, a leading remote health solution provider and the No. 11 healthcare company on the Inc. 5000 list of America’s fastest-growing private companies, today announced...
Hospital for Special Care Extends Altera Digital Health Partnership
Long-term acute care hospital on Sunrise EHR will also deploy Sunrise Health Record Altera Digital Health, a global health IT leader, today announced that Hospital for...
Elegen Launches ENFINIA™ IVT Ready DNA to Speed mRNA Synthesis
Elegen’s cell-free gene synthesis platform delivers full-length, high-complexity linear DNA with encoded poly(A) tails up to three times faster and free from bioburden, endotoxins and...